Jasper Therapeutics, Inc. (JSPR), a clinical-stage biotechnology company, on Friday announced plans for an underwritten public offering of shares of its common stock.
In lieu of common stock, certain investors may purchase pre-funded warrants, each offered together with accompanying common warrants to purchase shares of common stock.
The company intends to use the net proceeds to advance its preclinical and clinical development programs of briquilimab in mast-cell driven diseases, and for general corporate purposes, including capital expenditures, working capital, and administrative expenses.
Jasper Therapeutics closed trading in the overnight, 4.25% lesser at 2.4800 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.